Cognex (CGNX)
(Real Time Quote from BATS)
$42.44 USD
-0.04 (-0.09%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $42.40 -0.04 (-0.09%) 4:18 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Income Statements
Fiscal Year end for Cognex Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 838 | 1,006 | 1,037 | 811 | 726 |
Cost Of Goods | 236 | 284 | 277 | 206 | 190 |
Gross Profit | 601 | 722 | 760 | 605 | 536 |
Selling & Adminstrative & Depr. & Amort Expenses | 471 | 476 | 445 | 434 | 393 |
Income After Depreciation & Amortization | 131 | 246 | 315 | 171 | 143 |
Non-Operating Income | 5 | 4 | 4 | 16 | 20 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 135 | 251 | 319 | 187 | 163 |
Income Taxes | 22 | 35 | 39 | 11 | -41 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 113 | 216 | 280 | 176 | 204 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 113 | 216 | 280 | 176 | 204 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 154 | 271 | 340 | 198 | 167 |
Depreciation & Amortization (Cash Flow) | 24 | 25 | 25 | 28 | 24 |
Income After Depreciation & Amortization | 131 | 246 | 315 | 171 | 143 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 173.40 | 174.87 | 179.92 | 176.59 | 175.27 |
Diluted EPS Before Non-Recurring Items | 0.73 | 1.31 | 1.50 | 1.00 | 1.16 |
Diluted Net EPS (GAAP) | 0.65 | 1.23 | 1.56 | 1.00 | 1.16 |
Fiscal Year end for Cognex Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | 12/31/22 | |
---|---|---|---|---|---|
Sales | 196.67 | 197.24 | 242.51 | 201.12 | 239.43 |
Cost Of Goods | 61.63 | 54.47 | 62.83 | 57.38 | 69.87 |
Gross Profit | 135.04 | 142.77 | 179.68 | 143.74 | 169.56 |
SG&A, R&D, and Dept/Amort Expenses | 122.31 | 112.14 | 114.51 | 121.58 | 113.57 |
Income After SG&A, R&D, and Dept/Amort Expenses | 12.73 | 30.63 | 65.17 | 22.16 | 55.99 |
Non-Operating Income | 1.63 | -3.64 | 2.60 | 4.05 | 4.89 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | 14.35 | 27.00 | 67.78 | 26.22 | 59.23 |
Income Taxes | 3.13 | 8.09 | 10.30 | 0.60 | 3.92 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 11.23 | 18.92 | 57.47 | 25.62 | 55.31 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 11.23 | 18.92 | 57.47 | 25.62 | 55.31 |
Earnings Per Share Data | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | 12/31/22 |
---|---|---|---|---|---|
Average Shares | 172.57 | 173.35 | 173.62 | 173.90 | 173.90 |
Diluted EPS Before Non-Recurring Items | 0.11 | 0.10 | 0.32 | 0.05 | 0.27 |
Diluted Net EPS (GAAP) | 0.06 | 0.11 | 0.33 | 0.15 | 0.32 |